217 related articles for article (PubMed ID: 23343383)
1. Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus.
Rullo OJ; Woo JM; Parsa MF; Hoftman AD; Maranian P; Elashoff DA; Niewold TB; Grossman JM; Hahn BH; McMahon M; McCurdy DK; Tsao BP
Arthritis Res Ther; 2013 Jan; 15(1):R18. PubMed ID: 23343383
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
Wirestam L; Enocsson H; Skogh T; Padyukov L; Jönsen A; Urowitz MB; Gladman DD; Romero-Diaz J; Bae SC; Fortin PR; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Gordon C; Hanly JG; Wallace D; Isenberg DA; Rahman A; Merrill J; Ginzler E; Alarcón GS; Chatham WW; Petri M; Khamashta M; Aranow C; Mackay M; Dooley MA; Manzi S; Ramsey-Goldman R; Nived O; Steinsson K; Zoma A; Ruiz-Irastorza G; Lim S; Kalunian K; Inanc M; van Vollenhoven R; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken C; Askanase A; Stoll T; Bruce IN; Wetterö J; Sjöwall C
J Rheumatol; 2019 May; 46(5):492-500. PubMed ID: 30647177
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin - a biomarker for organ damage in paediatric lupus?
Briggs TA
Arthritis Res Ther; 2013 Mar; 15(2):110. PubMed ID: 23472880
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity.
Hinze CH; Suzuki M; Klein-Gitelman M; Passo MH; Olson J; Singer NG; Haines KA; Onel K; O'Neil K; Silverman ED; Tucker L; Ying J; Devarajan P; Brunner HI
Arthritis Rheum; 2009 Sep; 60(9):2772-81. PubMed ID: 19714584
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis.
Suzuki M; Wiers KM; Klein-Gitelman MS; Haines KA; Olson J; Onel KB; O'Neil K; Passo MH; Singer NG; Tucker L; Ying J; Devarajan P; Brunner HI
Pediatr Nephrol; 2008 Mar; 23(3):403-12. PubMed ID: 18202859
[TBL] [Abstract][Full Text] [Related]
6. Corrected Neutrophil Gelatinase-Associated Lipocalin (NGAL) Level Adjusted by the Scoring System of an Inflammation Index for Screening Renal Dysfunction in Patients with Systemic Inflammation.
Choi JW; Fujii T; Fujii N
Ann Clin Lab Sci; 2015; 45(3):248-55. PubMed ID: 26116587
[TBL] [Abstract][Full Text] [Related]
7. Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus.
Li YN; Hu FL; Dai YJ; Li R; Ma XX; Du Y; Feng M; Jia Y; Zhang CF; Zhu L; Ascherman DP; Li ZG
Lupus; 2014 Aug; 23(9):868-75. PubMed ID: 24704774
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil gelatinase-associated lipocalin as a biomarker for lupus nephritis.
Torres-Salido MT; Cortés-Hernández J; Vidal X; Pedrosa A; Vilardell-Tarrés M; Ordi-Ros J
Nephrol Dial Transplant; 2014 Sep; 29(9):1740-9. PubMed ID: 24711435
[TBL] [Abstract][Full Text] [Related]
9. Correlation between circulating osteopontin level in systemic lupus erythematosus and disease activity and associations between osteopontin polymorphisms and disease susceptibility: A meta-analysis.
Lee YH; Song GG
Lupus; 2017 Feb; 26(2):132-138. PubMed ID: 27307447
[TBL] [Abstract][Full Text] [Related]
10. Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.
Enocsson H; Wirestam L; Dahle C; Padyukov L; Jönsen A; Urowitz MB; Gladman DD; Romero-Diaz J; Bae SC; Fortin PR; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Gordon C; Hanly JG; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Ginzler E; Alarcón GS; Chatham WW; Petri M; Khamashta M; Aranow C; Mackay M; Dooley MA; Manzi S; Ramsey-Goldman R; Nived O; Steinsson K; Zoma AA; Ruiz-Irastorza G; Lim SS; Kalunian KC; Inanc M; van Vollenhoven RF; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken CA; Askanase A; Stoll T; Bruce IN; Wetterö J; Sjöwall C
J Autoimmun; 2020 Jan; 106():102340. PubMed ID: 31629628
[TBL] [Abstract][Full Text] [Related]
11. Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus.
Rana A; Minz RW; Aggarwal R; Anand S; Pasricha N; Singh S
Lupus; 2012 Sep; 21(10):1105-12. PubMed ID: 22759859
[TBL] [Abstract][Full Text] [Related]
12. Correlation of plasma osteopontin and neutrophil gelatinase-associated lipocalin levels with the severity and clinical outcome of pelvic inflammatory disease.
Tee YT; Wang PH; Yang SF; Tsai HT; Lee SK; Ko JL; Lin LY; Chen SC
Taiwan J Obstet Gynecol; 2014 Jun; 53(2):158-61. PubMed ID: 25017259
[TBL] [Abstract][Full Text] [Related]
13. Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus: Data from KORean lupus Network (KORNET) Registry.
Kim SK; Choe JY; Lee SS
J Rheumatol; 2017 Apr; 44(4):452-458. PubMed ID: 28298561
[TBL] [Abstract][Full Text] [Related]
14. Differences in Clinical Features and Mortality between Childhood-onset and Adult-onset Systemic Lupus Erythematosus: A Prospective Single-center Study.
Joo YB; Park SY; Won S; Bae SC
J Rheumatol; 2016 Aug; 43(8):1490-7. PubMed ID: 27252431
[TBL] [Abstract][Full Text] [Related]
15. The Prognostic Nutritional Index and Nutritional Risk Index Are Associated with Disease Activity in Patients with Systemic Lupus Erythematosus.
Correa-Rodríguez M; Pocovi-Gerardino G; Callejas-Rubio JL; Fernández RR; Martín-Amada M; Cruz-Caparros MG; Ortego-Centeno N; Rueda-Medina B
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30884776
[TBL] [Abstract][Full Text] [Related]
16. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus.
Brunner HI; Mueller M; Rutherford C; Passo MH; Witte D; Grom A; Mishra J; Devarajan P
Arthritis Rheum; 2006 Aug; 54(8):2577-84. PubMed ID: 16868980
[TBL] [Abstract][Full Text] [Related]
17. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus.
Sato JO; Corrente JE; Saad-Magalhães C
Lupus; 2016 Nov; 25(13):1479-1484. PubMed ID: 27230556
[TBL] [Abstract][Full Text] [Related]
18. Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children.
Hammad A; Mosaad Y; Elhanbly S; Youssef H; El Refaaey A; Elhusseini F; Bakr A
Lupus; 2013 Apr; 22(5):486-91. PubMed ID: 23554037
[TBL] [Abstract][Full Text] [Related]
19. Cell-bound complement activation products (CB-CAPs) have high sensitivity and specificity in pediatric-onset systemic lupus erythematosus and correlate with disease activity.
Hui-Yuen JS; Gartshteyn Y; Ma M; O'Malley T; Conklin J; Eichenfield AH; Imundo LF; Dervieux T; Askanase AD
Lupus; 2018 Dec; 27(14):2262-2268. PubMed ID: 30376789
[TBL] [Abstract][Full Text] [Related]
20. Relationship of systemic type I interferon activity with clinical phenotypes, disease activity, and damage accrual in systemic lupus erythematosus in treatment-naive patients: a retrospective longitudinal analysis.
Miyachi K; Iwamoto T; Kojima S; Ida T; Suzuki J; Yamamoto T; Mimura N; Sugiyama T; Tanaka S; Furuta S; Ikeda K; Suzuki K; Niewold TB; Nakajima H
Arthritis Res Ther; 2023 Feb; 25(1):26. PubMed ID: 36803843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
